Detalhe da pesquisa
1.
The BTLA-HVEM axis restricts CAR T cell efficacy in cancer.
Nat Immunol
; 25(6): 1020-1032, 2024 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-38831106
2.
Streamlined measurement of chimeric antigen receptor T-cell concentration, size, viability and two-color phenotyping during manufacturing.
Cytotherapy
; 26(5): 506-511, 2024 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-38483365
3.
Safety and efficacy of a novel anti-CD19 chimeric antigen receptor T cell product targeting a membrane-proximal domain of CD19 with fast on- and off-rates against non-Hodgkin lymphoma: a first-in-human study.
Mol Cancer
; 22(1): 200, 2023 12 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-38066564
4.
Integrated automated particle tracking microfluidic enables high-throughput cell deformability cytometry for red cell disorders.
Am J Hematol
; 94(2): 189-199, 2019 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-30417938
5.
Apoptosis: a Janus bifrons in T-cell immunotherapy.
J Immunother Cancer
; 11(4)2023 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-37055217
6.
Modulation of BCL-2 in Both T Cells and Tumor Cells to Enhance Chimeric Antigen Receptor T-cell Immunotherapy against Cancer.
Cancer Discov
; 12(10): 2372-2391, 2022 10 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-35904479
7.
The current landscape of single-cell transcriptomics for cancer immunotherapy.
J Exp Med
; 218(1)2021 01 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-33601414